Monoclonal antibodies
Location: United States, Massachusetts, Cambridge
Employees: 1-10
Total raised: $2.2M
Investors 1
| Date | Name | Website |
| - | Mass Medic... | massmedang... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.02.2014 | - | $1.2M | - |
| 30.07.2013 | - | $1M | - |
Mentions in press and media 5
| Date | Title | Description |
| 05.02.2014 | Sialix Raises $1.2M | Sialix, Inc., a Cambridge, Massachusetts-based biotechnology company developing products for the treatment and prevention of cancer, closed a $1.2m tranche of an angel-led financing. Backers included Boston Harbor Angels, Mass Medic Angels,... |
| 31.07.2013 | Pharma firm bets sialic acid could help explain link between diet and inflammatory diseases | It’s simultaneously developing two products: an antibody targeting solid tumors including ovarian, breast and colon cancers, and a nutritional supplement designed to tame the immune response to nonhuman sialic acid. Researchers have been ex... |
| 30.07.2013 | Sialix Closes $1M Angel Round | NEWTON, MA, Company developing products for the treatment and prevention of cancer and chronic inflammatory conditions, today announced the closing of a $1 million round of an angel-led financing. >> Click here for more funding dat... |
| 30.07.2013 | Sialix Raises $1M in Financing | Sialix, a Cambridge, Mass.-based developer of products that treat cancer and chronic inflammatory conditions, raised $1m in financing. Backers included Boston Harbor Angels, Mass Medic Angels, Launchpad Angels and Maine Angels, as well as o... |
| - | Pharma firm bets sialic acid could help explain link between diet and inflammatory diseases | A syndicate of East Coast angel investors pieced together $1 million to help a bicoastal startup commercialize products it thinks may prevent disease-causing inflammation linked to consumption of animal products such as red meat and dairy. ... |